ClinicalTrials.gg
DrugBiological

Magrolimab clinical trials

Also written Hu5F9-G4 and GS-4721.

studies test it
30
open now
0
in phase 3
3
first study started
2014

How each study uses magrolimab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Magrolimab
24

Development codes

Hu5F9-G4
16
GS-4721
8
ONO-7913
7

Other names

anti-CD47 monoclonal antibody Hu5F9-G4
1

Studies by the year they started

30 studies that test it; most in 2021 (7)

Studies that test magrolimab, by start year
YearStudies
20141
20151
20162
20171
20182
20192
20203
20217
20224
20234
20243

Who runs them

Industry 19 · Other 11

Gilead Sciences (12) · National Cancer Institute (NCI) (4) · M.D. Anderson Cancer Center (3) · Hoffmann-La Roche (2) · Ono Pharmaceutical Co., Ltd. (1) · University of California, San Francisco (1) · Ono Pharmaceutical Co. Ltd (1) · Acerta Pharma BV (1)

Often tested with

Tested in the same studies.

Azacitidine (2) · Danvatirsen (1) · Ceralasertib (1) · AZD5153 (1) · Enfortumab vedotin (1) · Niraparib (1) · Tiragolumab (1) · Sacituzumab govitecan (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test magrolimab.

Studies

Open first, then newest update. How each study uses magrolimab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 30

See all 30 studies that test magrolimab →

Given beside what is tested · 5 — magrolimab is usual care or a partner of the new treatment

Codes

What other systems call magrolimab · ClinicalTrials.gg INT001017

  • MeSH (NLM) C000629291magrolimabConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 90YIEHRFJ9MAGROLIMABConfirmed FDA, NLM
  • NCI Thesaurus C117730MagrolimabOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.